Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $409,635 - $480,704
400 Added 0.94%
42,900 $45.1 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $883,200 - $1.07 Million
1,000 Added 2.41%
42,500 $44.7 Million
Q1 2024

May 10, 2024

SELL
$902.69 - $993.35 $33 Million - $36.4 Million
-36,600 Reduced 46.86%
41,500 $39.9 Million
Q4 2023

Feb 09, 2024

SELL
$775.18 - $881.7 $27 Million - $30.7 Million
-34,800 Reduced 30.82%
78,100 $68.6 Million
Q3 2023

Nov 09, 2023

BUY
$692.45 - $844.37 $42 Million - $51.3 Million
60,700 Added 116.28%
112,900 $92.9 Million
Q2 2023

Aug 10, 2023

BUY
$700.03 - $830.35 $17.3 Million - $20.5 Million
24,700 Added 89.82%
52,200 $37.5 Million
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $9.19 Million - $11.2 Million
13,500 Added 96.43%
27,500 $22.6 Million
Q4 2022

Feb 09, 2023

SELL
$705.89 - $766.39 $7.06 Million - $7.66 Million
-10,000 Reduced 41.67%
14,000 $10.1 Million
Q3 2022

Nov 10, 2022

BUY
$573.97 - $724.32 $5.74 Million - $7.24 Million
10,000 Added 71.43%
24,000 $16.5 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $15.8 Million - $18.5 Million
-26,500 Reduced 65.43%
14,000 $9.78 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $23.2 Million - $27.6 Million
40,500 New
40,500 $24.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.